EBNEO Commentary: De‐ MIST ‐ifying the 2‐year outcomes of non‐invasive surfactant therapy
Acta Paediatrica · 2024
DOI: 10.1111/apa.17116 ↗Kurz gefasst
Kommentar in der Zeitschrift Acta Paediatrica, 2024. Verfasst von Lucy Loft und 2 weiteren Autor:innen. Beteiligte Einrichtung: Neonatology, The Royal Women's Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Pulmonary Surfactants, Respiratory Distress Syndrome, Newborn, Bronchopulmonary Dysplasia. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Government of Victoria, National Health and Medical Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neonatology, The Royal Women's Hospital, Melbourne, Victoria, Australia.
- Neonatal Research, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
- Neonatology, Mercy Hospital for Women, Melbourne, Victoria, Australia.
- Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: David G Tingay
Förderung
- State Government of Victoria
- National Health and Medical Research Council
Zitieren
APA
Loft, L., Ferguson, K. N., & Tingay, D. G. (2024). EBNEO Commentary: De‐ MIST ‐ifying the 2‐year outcomes of non‐invasive surfactant therapy. Acta Paediatrica. https://doi.org/10.1111/apa.17116
Vancouver
Loft L, Ferguson KN, Tingay DG. EBNEO Commentary: De‐ MIST ‐ifying the 2‐year outcomes of non‐invasive surfactant therapy. Acta Paediatrica. 2024. doi:10.1111/apa.17116
BibTeX
@article{Loft2024,
author = {Loft, Lucy and Ferguson, Kristin N and Tingay, David G},
title = {EBNEO Commentary: De‐ MIST ‐ifying the 2‐year outcomes of non‐invasive surfactant therapy},
journal = {Acta Paediatrica},
year = {2024},
doi = {10.1111/apa.17116}
}
EUVIMED